Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lydia Visintin"'
Autor:
Georgina V. Long, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, Julie R. Howle, Matteo S. Carlino, Lydia Visintin, Lauren E. Haydu, Alexander M. Menzies
PDF file, 53KB, A survival curve of all patients as outlined on page 23 of the paper:Supplementary Figure S1. Overall survival from distant metastasis based on BRAF and inhibitor status for all patients (n=308).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fcf085f6d37397ccff58cee1f5a28b
https://doi.org/10.1158/1078-0432.22452116
https://doi.org/10.1158/1078-0432.22452116
Autor:
Georgina V. Long, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, Julie R. Howle, Matteo S. Carlino, Lydia Visintin, Lauren E. Haydu, Alexander M. Menzies
PDF file, 55KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ebc733288445a092fd9a7dc6bd22a99
https://doi.org/10.1158/1078-0432.22452113.v1
https://doi.org/10.1158/1078-0432.22452113.v1
Autor:
Georgina V. Long, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, Julie R. Howle, Matteo S. Carlino, Lydia Visintin, Lauren E. Haydu, Alexander M. Menzies
Purpose: Certain clinicopathologic features correlate with BRAF mutation status in melanoma including younger age and primary subtype. This study sought to determine the BRAF mutation status by age-decade and whether BRAF-mutant genotypes correlated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c9167b593f5b8d6980805f226417da
https://doi.org/10.1158/1078-0432.c.6522383.v1
https://doi.org/10.1158/1078-0432.c.6522383.v1
Autor:
Florian Honeyball, Lydia Visintin, Theresa Nielsen, Benjamin Shum, Anna J. Lomax, Catriona M. McNeil, Brent O’Carrigan, Robyn P. M. Saw
Publikováno v:
Clinical journal of oncology nursing. 21(4)
Background Targeted therapy and immunotherapy agents for advanced melanoma are associated with novel toxicities. Melanoma clinical nurse consultants (CNCs) provide multifaceted clinical care. . Objectives The objective was to evaluate the type of sup
Autor:
Alexander M. Menzies, Georgina V. Long, Lydia Visintin, John F. Thompson, Richard A. Scolyer, Richard F. Kefford, Matteo S. Carlino, Lauren E. Haydu, Julie Howle
Publikováno v:
Clinical Cancer Research. 18:3242-3249
Purpose: Certain clinicopathologic features correlate with BRAF mutation status in melanoma including younger age and primary subtype. This study sought to determine the BRAF mutation status by age-decade and whether BRAF-mutant genotypes correlated